Vestibular system impairment tied to fall risk in Alzheimer’s patients
Mar 18, 2022
A significant association was seen between semicircular canal function with lower likelihood of falls in adjusted analysis.
Construction, renovation plans outweigh buying, selling in 2017: survey
By
Lois A. Bowers
Feb 14, 2017
Senior living construction and renovation projects, especially in assisted living and memory care, are on the rise, whereas efforts to buy or sell existing properties have waned, according to the findings...
More news for Monday, Dec. 19
Dec 19, 2016
Crooks target assisted living facility … Labor relations board likely to favor employers under Trump … Is Alzheimer’s disease hereditary? … New drug approvals down in 2016 …...
The 10 highest-ranking senior living operators in 2016
By
Lois A. Bowers
Dec 06, 2016
SeniorAdvisor.com has released its Best of 2017 Awards, honoring those operators that have received high marks on the Austin, TX-based online ratings and reviews site in 2016. See the companies, states...
AAN: Higher fitness level tied to lower Alzheimer’s disease risk
Feb 28, 2022
A graded association was seen between levels of cardiorespiratory fitness and the incidence of Alzheimer’s disease and related disorders.
Few older adults knowledgeable about aducanumab for Alzheimer’s disease
Feb 25, 2022
Less than one-quarter of older adults report they would want to take aducanumab (Aduhelm).
Biden makes another push for cancer moonshot initiative
Sep 13, 2022
The president likened JFK’s space race to his own effort to slash cancer rates by 50% in the next 25 years.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Midlife cardiovascular conditions, risk factors linked to cognitive decline
Jan 06, 2022
Most cardiovascular conditions more strongly linked to cognition among women.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.